Cited 0 time in
Effect of low sodium and high potassium diet on lowering blood pressure and cardiovascular events
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Byung Sik | - |
| dc.contributor.author | Yu, Mi-Yeon | - |
| dc.contributor.author | Shin, Jinho | - |
| dc.date.accessioned | 2024-01-15T07:30:18Z | - |
| dc.date.available | 2024-01-15T07:30:18Z | - |
| dc.date.issued | 2024-01 | - |
| dc.identifier.issn | 2635-6325 | - |
| dc.identifier.issn | 2056-5909 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/194508 | - |
| dc.description.abstract | Incorporating aggressive lifestyle modifications along with antihypertensive medication therapy is a crucial treatment strategy to enhance the control rate of hypertension. Dietary modification is one of the important lifestyle interventions for hypertension, and it has been proven to have a clear effect. Among food ingredients, sodium and potassium have been found to have the strongest association with blood pressure. The blood pressure-lowering effect of a low sodium diet and a high potassium diet has been well established, especially in hypertensive population. A high intake of potassium, a key component of the Dietary Approaches to Stop Hypertension (DASH) diet, has also shown a favorable impact on the risk of cardiovascular events. Additionally, research conducted with robust measurement methods has shown cardiovascular benefits of low-sodium intake. In this review, we aim to discuss the evidence regarding the relationship between the low sodium and high potassium diet and blood pressure and cardiovascular events. | - |
| dc.format.extent | 13 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Korean Society of Hypertension | BioMed Central | - |
| dc.title | Effect of low sodium and high potassium diet on lowering blood pressure and cardiovascular events | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.1186/s40885-023-00259-0 | - |
| dc.identifier.scopusid | 2-s2.0-85180946822 | - |
| dc.identifier.wosid | 001134229300002 | - |
| dc.identifier.bibliographicCitation | Clinical Hypertension, v.30, no.1, pp 1 - 13 | - |
| dc.citation.title | Clinical Hypertension | - |
| dc.citation.volume | 30 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 13 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART003040676 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | esci | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
| dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
| dc.subject.keywordPlus | K+-INDUCED NATRIURESIS | - |
| dc.subject.keywordPlus | MODEST SALT REDUCTION | - |
| dc.subject.keywordPlus | 24-H URINARY SODIUM | - |
| dc.subject.keywordPlus | CHLORIDE COTRANSPORTER | - |
| dc.subject.keywordPlus | SCIENTIFIC STATEMENT | - |
| dc.subject.keywordPlus | CL-COTRANSPORTER | - |
| dc.subject.keywordPlus | ORAL POTASSIUM | - |
| dc.subject.keywordPlus | NCC ACTIVITY | - |
| dc.subject.keywordPlus | ALL-CAUSE | - |
| dc.subject.keywordPlus | EXCRETION | - |
| dc.subject.keywordAuthor | Sodium | - |
| dc.subject.keywordAuthor | Potassium | - |
| dc.subject.keywordAuthor | Blood pressure | - |
| dc.subject.keywordAuthor | Hypertension | - |
| dc.subject.keywordAuthor | Cardiovascular event | - |
| dc.identifier.url | https://clinicalhypertension.biomedcentral.com/articles/10.1186/s40885-023-00259-0 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
